SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
From the Blogosphere
SurModics Misses – Analyst Blog
|
|
|
SurModics’ (SRDX) fourth-quarter earnings per share came in at 18 cents, below the Zacks Consensus Estimate of 20 cents. The company reported revenues of $19.2 million, down 17% compared to the year ago period. In addition to quarterly results, SurModics came out with fiscal year 2009 results. The company recorded revenues of $121.5 million in 2009, up 25%, compared to $97 million in the previous year and earnings per share of $1.07 for 2009. <>On a business unit basis, apart from Diagnostic, revenues from the other three segments – Cardiovascular, Ophthalmology and Other Markets, recorded a<><><><><><><><><><><>< />< />< />< />< /><>< /><>< /><>< /><>< /><>< /><>< /><><>< /><>< /><>< />< />...
|
MFI Stock List Additions for Week Ending March 6, 2009
|
|
|
Here are the latest additions to the MFI stock universe:
- Almost Family Inc. (AFAM)
- The Corporate Executive Board Company (EXBD)
- Dun & Bradstreet Corp. (DNB)
- Expedia Inc. (EXPE)
- Intrepid Potash Inc. (IPI)
- lululemon athletica, Inc. (LULU)
- Medtronic Inc. (MDT)
- Omnicom Group Inc. (OMC)
- Qiao Xing Mobile Communication Co Ltd. (QXM)
- QLT Inc. (QLTI)
- Somanetics Corp. (SMTS)
- SurModics Inc. (SRDX)
To qualify for the list, a stock must appear for the first time in the past six months in the top 100 for any of the following minimum market cap thresholds: $1MM, $5MM, $10MM, $15MM, $20MM, $25MM, $50MM, $75MM, $100MM, ...
|
Analysis of Stem Cell Index YTD
|
|
|
The accompanying table includes statistics for the 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which is down 13.8% at a value of 3,387 from a 2/22/09 inception date value of 3,928.
The index is down 30.6% over the past year on an equal-weight basis, compared to losses of 31.2% for the Healthcare Sector SPDR (XLV), 19% for iShares Nasdaq Biotech (IBB), 14.7% for SPDR S&P Biotech (XBI), 29.7% for PowerShares Biotech & Genome (PBE), and 46.1% for the S&P 500 SPDR (SPY).
Below is a profile for each company, including a summary of their business and researc...
|
The Dirty Dozen: The Top Twelve stocks to short right now (PCLN)(PPD)(NVEC)(SBNY)(RATE)(JOSB)(NETL)(WIRE)(SRDX)(JRCC)(TWP)(CONN)
If you're not shorting stocks right now, chances are you're handing your money straight  over to the bears.
If you can't beat them, join them. We've compiled a list of the top 12 stocks to short right now in 2009. Our selection criteria includes (among other things):
- Greater than 30% Short Interest
- Current Price Greater than $10.00
- 5 cans of Red Bull
Â
read more
|
Closing Bell: Market surges after yo-yo session; WM and AIG up, SRDX, CPST, STT all down
Filed under: After the bell, Market matters, Amer Intl Group (AIG), Washington Mutual (WM)  The markets could have changed their name to 'Yo-Yo' today rather than 'Skydiver.' It wasn't the VIX reaching multi-year highs of 40 that ran us up. It wasn't last night's intervention. It was the first overseas curbing of short selling financial stocks in the U.K. and then the word that the government was preparing a new version of the Resolution Trust Corporation.
Dow 11,010.74 +401.08 +3.78%
Nasdaq 2,199.10 +100.25 +4.78%
S&P 500 1,202.86 +46.47 +4.02%
10 Yr Bond(%) 3.432% +0.022%
52-week lows
<>Top Analys...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on SRDX |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About SurModics Inc.
- Answers.com
